Guardant Health Inc. (GH)
Are Medical Stocks Lagging Guardant Health (GH) This Year?
Here is how Guardant Health (GH) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test
On Tuesday, Guardant Health, Inc. GH announced that Palmetto GBA, a Medicare administrative contractor that administers the Molecular Diagnostics Services program (MolDX), granted coverage for the Guardant Reveal test to monitor for disease recurrence in patients with colorectal cancer (CRC) following curative intent therapy.
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test. The post Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone appeared first on Investor's Business Daily.
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Guardant Health Stock Flashing Surefire ‘Buy' Signal
Biotechnology stock Guardant Health (GH) is trading at 15-month highs today, last seen up 7% at $38.28. Shares have added 107.7% over the last nine months, and now stand nearly 42% higher in 2024.
Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript
Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript
Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Guardant Health (GH) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.73 per share a year ago.
Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Guardant Health (GH) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why Guardant Health Stock Was the Picture of Health Today
There's nothing like free publicity to help goose the sales of a relatively new product.
Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GameHost Announces Regular Monthly Dividend for October
Not intended for distribution to U.S. newswire services or for dissemination in the U.S. RED DEER, AB / ACCESSWIRE / October 17, 2024 / Gamehost Inc. (‘Gamehost', the ‘Company') (TSX:GH) has declared a cash dividend for the month of October 2024 of $0.04 (CDN) per common share, which equates to $0.48 (CDN) per common share on an annualized basis. The dividend will be paid on November 15, 2024 to shareholders of record on October 31, 2024.
